Amphotericin
Amphotericin is indicated in:
- intestinal candidiasis by oral route - tablets
- systemic fungal infections by slow intravenous infusion
Caution must be exercised:
- with corticosteroids
- when given parenterally - toxicity is the rule rather than the exception; close supervision is necessary with:
- hepatic and renal function tests
- FBC and plasma electrolytes
- with other nephrotoxic drugs
- if frequent changes of injection site - irritation
- with co-administration of anti-neoplastics
Possible adverse effects include:
- fever
- rash
- nausea, vomiting
- diarrhoea
- anorexia
- myalgia and arthralgia
- headache
- biochemical disturbances e.g. hypokalaemia, hypomagnesiumaemia
- anaemia
- arrhythmias
- neurosensory disturbances e.g. hearing loss, peripheral neuropathy, diplopia
- seizures
- nephrotoxicity
- hepatotoxicity
- phlebitis
- anaphylaxis
The summary of product characteristics must be consulted before prescribing this drug.
Reference:
- British National Formulary (BNF); Amphotericin. NICE Evidence Services (UK access only).
Related pages
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.